Seminars in Arthroplasty
Volume 20, Issue 4 , Pages 241-250, December 2009

The Multimodal Approach for the Prevention of Thromboembolic Disease After Total Joint Arthroplasty

  • Alejandro González Della Valle, MD

      Affiliations

    • Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA
    • Weill Medical College of Cornell University, New York, NY, USA
    • Corresponding Author InformationAddress reprint requests to Alejandro González Della Valle, MD, Hospital for Special Surgery, 535 East 70th St, New York, NY 10,021
  • ,
  • Francis Jeshira Reynoso, MD

      Affiliations

    • Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA
  • ,
  • Judith Ben Ari, MD

      Affiliations

    • Woodhull Medical Center, Brooklyn, NY, USA
  • ,
  • Eduardo Salvati, MD

      Affiliations

    • Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, NY, USA
    • Weill Medical College of Cornell University, New York, NY, USA

Total hip and knee arthroplasties carry an increased risk for thromboembolic disease. A multimodal prophylaxis protocol developed at the Hospital for Special Surgery and fully implemented since 1995, consists of stratifying the individual patient's risk and implementing a series of safe preventive measures before, during, and after surgery to reduce the risk of venous thromboembolism and bleeding. The measures include discontinuation of procoagulant medication and autologous blood donation before surgery; the use of hypotensive epidural anesthesia and intraoperative intravenous heparin after acetabular work during total hip arthroplasty; the use of pneumatic compression devices, elastic stockings, and frequent, vigorous dorsiflexion of the ankles; and prompt mobilization of the patient after surgery to diminish venous stasis. If these safe measures are observed, postoperative pharmacologic prophylaxis does not need to be aggressive in the patients without predisposing factors for venous thromboembolism and who mobilize promptly, thus diminishing the morbidity and mortality associated with the routine use of potent anticoagulants and the overall cost of care. Our clinical experience with close to 10,000 total hip and knee replacements demonstrates that this multimodal prophylaxis is safe and effective, resulting in a very low prevalence of thromboembolism, bleeding, and all-cause mortality.

Keywords: thromboembolic disease, total joint arthroplasty

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1045-4527(09)00060-1

doi:10.1053/j.sart.2009.10.008

Seminars in Arthroplasty
Volume 20, Issue 4 , Pages 241-250, December 2009